# Korea Institute of Radiological and Medical Sciences

Source: https://nuclide.cc/institutions/kirams/  
Nuclide record `kirams` (Institution). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)"; commercial use needs a licence.

## TL;DR

South Korea's government radiation-medicine institute, which runs the national cancer hospital and the cyclotrons that make the country's research isotopes.

## Summary

KIRAMS is a government-funded research institute combining radiological research with the Korea Cancer Center Hospital, which has operated since 1963. Its cyclotrons supply research isotopes to Korean groups, and in 2025 it was reported to have received approval from Korea's Nuclear Safety and Security Commission to begin cyclotron production of actinium-225, the alpha emitter behind the next generation of radioligand therapies. That approval is reported here from an English-language news account rather than a KIRAMS page, and is flagged as such.

KIRAMS also convenes the national alpha-radiopharmaceutical research consortium with Korean industry, which is how the state institute and the listed developers (FutureChem, CellBion) coordinate on isotope supply.

## Fields

- Kind: Institution
- Last checked: 2026-09-22
- Also known as: KIRAMS
- City: Seoul, KR
- Type: research-institute
- Website: https://www.kirams.re.kr/

## Sources

- Korea Cancer Center Hospital (KIRAMS), history from 1963: https://www.kcch.re.kr/eng/conts/101001000000000.do
- News report: KIRAMS approved to produce actinium-225 (Asia Business Daily English edition, June 2025): https://view.asiae.co.kr/en/article/2025060415574246814

## Connected records

- isotopes: [Actinium-225](https://nuclide.cc/isotopes/ac-225/)
- companies: [CellBion](https://nuclide.cc/companies/cellbion/), [FutureChem](https://nuclide.cc/companies/futurechem/)
- institutions: [Korean Society of Nuclear Medicine](https://nuclide.cc/institutions/ksnm/)

---
JSON: https://nuclide.cc/api/v1/entities/kirams.json